[HTML][HTML] 68Ga-labeled prostate-specific membrane antigen ligand positron emission tomography/computed tomography for prostate cancer: a systematic review and …

FE von Eyben, M Picchio, R von Eyben, H Rhee… - European urology …, 2018 - Elsevier
Context 68 Gallium prostate-specific membrane antigen (PSMA) ligand 68 Ga-HBED-CC-
PSMA (68 Ga-PSMA) is a promising radiotracer for positron emission tomography …

A perspective on the evolving story of PSMA biology, PSMA-based imaging, and endoradiotherapeutic strategies

DS O'Keefe, DJ Bacich, SS Huang… - Journal of Nuclear …, 2018 - Soc Nuclear Med
In this review, we cover the evolution of knowledge on the biology of prostate-specific
membrane antigen (PSMA) and its translation to therapy. The usual key to discovery is a …

Effect on survival of androgen deprivation therapy alone compared to androgen deprivation therapy combined with concurrent radiation therapy to the prostate in …

LMS Boevé, MCCM Hulshof, AN Vis, AH Zwinderman… - European urology, 2019 - Elsevier
Background The cornerstone of standard treatment for patients with primary bone metastatic
prostate cancer (mPCa) is androgen deprivation therapy (ADT). Retrospective studies …

Preclinical evaluation of 18F-PSMA-1007, a new prostate-specific membrane antigen ligand for prostate cancer imaging

J Cardinale, M Schäfer, M Benešová… - Journal of Nuclear …, 2017 - Soc Nuclear Med
In recent years, several radiotracers targeting the prostate-specific membrane antigen
(PSMA) have been introduced. Some of them have had a high clinical impact on the …

Complexities of prostate cancer

S Wasim, SY Lee, J Kim - International journal of molecular sciences, 2022 - mdpi.com
Prostate cancer has a long disease history and a wide variety and uncertainty in individual
patients' clinical progress. In recent years, we have seen a revolutionary advance in both …

Proposal for a structured reporting system for prostate-specific membrane antigen–targeted PET imaging: PSMA-RADS version 1.0

SP Rowe, KJ Pienta, MG Pomper… - Journal of Nuclear …, 2018 - Soc Nuclear Med
As medical imaging has grown progressively more complicated and subspecialized in
recent decades, several standardized reporting systems have been proposed for a variety of …

Intraindividual comparison of [68 Ga]-Ga-PSMA-11 and [18F]-F-PSMA-1007 in prostate cancer patients: a retrospective single-center analysis

S Hoberück, S Löck, A Borkowetz, U Sommer… - EJNMMI research, 2021 - Springer
Background The analysis aimed to compare the radiotracers [68 Ga]-Ga-PSMA-11 and [18
F]-F-PSMA-1007 intraindividually in terms of malignant lesions, mi (molecular-imaging) TNM …

68Ga or 18F for prostate cancer imaging?

C Kesch, C Kratochwil, W Mier, K Kopka… - Journal of Nuclear …, 2017 - Soc Nuclear Med
Prostate-specific membrane antigen (PSMA) is a type II transmembrane glycoprotein with
enzymatic carboxypeptidase activity. Expression is seen at low levels in the brain, kidneys …

Outcomes of Primary Lymph Node Staging of Intermediate and High Risk Prostate Cancer with 68Ga-PSMA Positron Emission Tomography/Computerized …

JW Yaxley, S Raveenthiran, FX Nouhaud… - The Journal of …, 2019 - auajournals.org
Purpose: The majority of men who undergo pelvic lymph node dissection at radical
prostatectomy have benign lymph node histology. The aim of this study was to assess the …

Prostate Specific Membrane Antigen Targeted 18F-DCFPyL Positron Emission Tomography/Computerized Tomography for the Preoperative Staging of High Risk …

MA Gorin, SP Rowe, HD Patel, I Vidal… - The Journal of …, 2018 - auajournals.org
Purpose: We prospectively evaluated the diagnostic performance of prostate specific
membrane antigen targeted 18F-DCFPyL positron emission tomography/computerized …